Peer Review History
Original SubmissionOctober 1, 2019 |
---|
PONE-D-19-27478 Negative impact and factors of physicians’ diagnostic errors in malpractice claims in Japan PLOS ONE Dear Dr. Watari, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. The paper reports an interesting analysis of the malpractice in Japan. The statistical analysis and results sound but the addition of some details will make it clearer to the readers for example a brief description of the database used in the study providing information useful to evaluate the characteristics of the sample used as highlighted by the reviewers. We would appreciate receiving your revised manuscript by Jan 26 2020 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols Please include the following items when submitting your revised manuscript:
Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. We look forward to receiving your revised manuscript. Kind regards, Lorenza Scotti, PhD Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at http://www.journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and http://www.journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf 1. Please refer to any post-hoc corrections to correct for multiple comparisons during your statistical analyses. if these were not performed please justify the reasons. Please refer to our statistical reporting guidelines for assistance (https://journals.plos.org/plosone/s/submission-guidelines.#loc-statistical-reporting). 2. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. In your revised cover letter, please address the following prompts: a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. We will update your Data Availability statement on your behalf to reflect the information you provide. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: No ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: No Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: This is a report that analyzes diagnosis-related cases in a database of Japanese malpractice claims. Over a period of 56 years, they identified 709 cases that involved a diagnostic error, and in this paper they describe the diseases\\conditions involved in these cases, the clinical specialties that were involved, and other descriptive data, in comparison to cases that did not involve diagnostic error. The methods seem appropriate, the statistical analyses are fine, and results are reasonable and interesting. One of the conclusions, that diagnostic errors are common is not supported and should be removed - the incidence of diagnostic errors was not studied here. The limitations should emphasize that malpractice claims are a highly select group of errors, and may not be representative of diagnostic errors generally. If the incidence of diagnostic error is anywhere similar to that in the US, there may have been many millions of diagnostic error over the past 56 years, whereas only 709 cases were studied in this analysis. Minor problems; Please fix these: Please define ‘acceptance rate’. That isn’t a widely recognized term in the US Page 5 Lines 67-9 Sentence is unclear. Are cognitive errors the most common etiology in these cases, or are they more common in dx error cases than in other types? Page 6 Line 78 Do you mean what diagnosis were found in the diagnostic error cases? Page 12 Line 152 Do you mean that the most common disease category in cases of DERC was neoplasm? They it reads, it sounds like neoplasm was the most common diagnostic error, which is confusing. Page 15 Line 165 Same issue – the sentence implies these conditions are diagnostic errors; they are not; they are just names of conditions. Lines 165-9 It isn’t clear why this breakout is important Page 27 Line 253-5 This sentence isn’t clear. There was no training before 2018? What kind of training? Page 28 Line 259-60 Do you mean there aren’t enough ER physicians to adequately staff the ER’s? The sentence implies the number of ER’s is greater than the number of MD’s – I doubt it. Conlusions: The sentence about developing coordinated risk management in exam rooms isn’t clear. Table 3 I would suggest grouping all the <1% departments together in a “<1%” category instead of listing them separately Reviewer #2: This paper presents an analysis (primarily descriptive in nature) of Japanese malpractice claims relating to diagnostic errors, with the goal of characterizing the types of injuries and physicians involved and the outcomes of claims. The abstraction and statistical methods appear appropriate. The findings are only of moderate interest, but the paper has a nice discussion section setting them in the context of other literature. It is not clear how representative the data are of all malpractice claims involving diagnostic errors in Japan, or of all diagnostic errors. It would be helpful to add some background, if possible, regarding how frequently adverse events result in malpractice claims in Japan and what types of selection bias are known to occur. (In the US, for example, only 2-3% of adverse events result in claims and they are disproportionately those involving quite severe injuries). The fact that over half the claims in this sample are death cases and that plaintiffs are, on average, quite young suggests they are not very representative (in the US, at least, medical errors and adverse events disproportionately affect the elderly, and the proportion of malpractice claims involving death is around 20%). This would provide helpful context for understanding why the number of claims in the sample is so low (1,800 over 56 years, or about 32 per year thoughout the entire country). I do not know anything about the Japanese Westlaw database used, but the authors should provide reassurance that it does indeed contain a comprehensive record of all malpractice claims, as they assert. In the US, all we see in Westlaw are reported malpractice cases—meaning, only the tiny fraction of all claims that result in a trial with a written decision. For that reason, Westlaw databases are considered useless for trying to understand the characteristics of the universe of all malpractice claims, because the small number that go to a bench trial are highly unlikely to be representative of the group. I suspect the Japanese database has the same characteristics, in which case this study should only be published if the authors rewrite it to make clear what they are actually showing: the characteristics of the few cases that make it to a judgment that is reported. They should present contextual information to enable the reader to understand how selective that sample is—specifically, what is known about the percentage of all adverse events that become malpractice claims, and the percentage of all malpractice claims that get to the stage that would permit them to be included in this database. The study period employed is very long; they look back as far as 1961. Given the vast changes in medicine over the past half century, it seems likely that the characteristics of errors have changed over that period. Therefore, I was surprised not to see any subanalyses of claim characteristics by time period. The descriptive statistics would also be more interesting if, in addition to the totals, the authors broke them down by accepted and non-accepted claims. Is the median indemnity payment calculated among all claims, or only those that received at least some payment? ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step. |
Revision 1 |
PONE-D-19-27478R1 Negative impact and factors of physicians’ diagnostic errors in malpractice claims in Japan PLOS ONE Dear Dr. Watari, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Although the manuscript is improved after addressing reviewer's suggestions, a few minor revisions are still needed. We would appreciate receiving your revised manuscript by Apr 17 2020 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols Please include the following items when submitting your revised manuscript:
Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. We look forward to receiving your revised manuscript. Kind regards, Lorenza Scotti, PhD Academic Editor PLOS ONE [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: (No Response) Reviewer #2: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: No ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Thank you for addressing my concerns in the revised version - the revised version is much improved as a result. Reviewer #2: The authors have been reasonably responsive to the reviewer comments. They appear to have missed the point of the comment about separating claims that did and did not result in a payment, however. Because the authors’ aim is to say something about the nature of diagnostic errors using malpractice claims as a data source, their study question is more directly answered by examining claims that are meritorious (i.e. actually do involve an error) than by analyzing all claims, many of which (if data from several other countries are any indication) are nonmeritorious—i.e., do not actually relate to injuries due to an error. In the US, for example, estimates of the proportion of claims that are nonmeritorious range from a third to over half of all claims. That’s why it is especially useful, given the severe limitations of this data source, to isolate claims with the greatest signal about actual errors. Payment is an imperfect proxy measure of that; claims get paid sometimes even when they don’t involve errors. But it’s better than nothing. Some of the edits made to the manuscript read a bit rough; they could benefit from editing by a native English speaker and from the following revisions to the limitations section: - The new limitation added on p.18 (“there is no existing data on the frequency with which adverse events lead to malpractice claims in Japan”) should be called out as separate from the first limitation, as it is a wholly different point. This limitation should be labeled “Second,” and the limitations that followed should be renumbered accordingly. - The sentence beginning “Furthermore, there are possibly much more cases…” on p.19 does not belong where it is inserted. It is again a separate point, and it is the same point the authors already make farther down the page (“Third, many settlements…”). Finally, the revisions do a good job overall of acknowledging that malpractice claims aren’t a very good source of information about all diagnostic errors, but they could be improved by revising a few remaining instances where the authors talk about errors rather than claims: - P.16: “about 40% of the claims were considered diagnostic errors” should instead read “about 40% of the claims involved allegations of a diagnostic error” - P.16: “The initial diagnoses most likely to lead to diagnostic errors were” should read “The diagnoses most commonly associated with allegations of diagnostic errors in malpractice claims were” - P.20: “diagnostic errors in the malpractice claims data from Japan were common” should instead read “diagnostic errors were a common allegation in malpractice claims” - P.20: “and tended to result in poor patient outcomes” implies causality. It should instead read “and tended to involve allegations of relatively severe patient outcomes compared to other types of malpractice claims.” ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step. |
Revision 2 |
PONE-D-19-27478R2 Negative impact and factors of physicians’ diagnostic errors in malpractice claims in Japan PLOS ONE Dear Dr. Watari, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Although the manuscript has been improved after the first revision, a few points raised by Reviewer 2 need to be addressed. We would appreciate receiving your revised manuscript by May 29 2020 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols Please include the following items when submitting your revised manuscript:
Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. We look forward to receiving your revised manuscript. Kind regards, Lorenza Scotti, PhD Academic Editor PLOS ONE [Note: HTML markup is below. Please do not edit.] [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step. |
Revision 3 |
Factors and impact of physicians’ diagnostic errors in malpractice claims in Japan PONE-D-19-27478R3 Dear Dr. Watari, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Cesario Bianchi Academic Editor PLOS ONE Additional Editor Comments (optional): Dear Dr Watari, Thank you for carefully revising our manuscript according to reviewer #2 critics. Your manuscript is now acceptable for publication in our journal. Reviewers' comments: |
Formally Accepted |
PONE-D-19-27478R3 Factors and impact of physicians’ diagnostic errors in malpractice claims in Japan Dear Dr. Watari: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Cesario Bianchi Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .